From July 1, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 229,000 shares, representing 0.03% for HKD 0.21 million under the buyback announced on June 2, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.19 HKD | +8.18% | +33.71% | -13.14% |
1st Jan change | Capi. | |
---|---|---|
-13.14% | 104M | |
+21.63% | 44.12B | |
+22.99% | 22.71B | |
+18.22% | 15.15B | |
+12.66% | 13.61B | |
+60.18% | 13.34B | |
-8.35% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.92% | 5.63B |
- Stock Market
- Equities
- 1652 Stock
- News Fusen Pharmaceutical Company Limited
- Tranche Update on Fusen Pharmaceutical Company Limited's Equity Buyback Plan announced on June 2, 2022.